DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» RPS6KA4
RPS6KA4
Profiling Data
Supplementary Material DNA Methylation in Inflammatory Pathways Modifies the Association Between BMI and Adult-Onset Non- Atopic
R Graphics Output
The Mtor Substrate S6 Kinase 1 (S6K1)
The Mtor Substrate S6 Kinase 1 (S6K1) Is a Negative Regulator of Axon Regeneration and a Potential Drug Target for Central Nervous System Injury
Activation of Diverse Signalling Pathways by Oncogenic PIK3CA Mutations
Marine-Derived 2-Aminoimidazolone Alkaloids. Leucettamine B-Related Polyandrocarpamines Inhibit Mammalian and Protozoan DYRK & CLK Kinases
RPS6KA4 Antibody (C-Term) Purified Rabbit Polyclonal Antibody (Pab) Catalog # Ap21318b
PRODUCTS and SERVICES Target List
Supplementary Information
Proteome Profiler™ Human Phospho-MAPK Array
Table SI. Enriched Genes in the Upregulated Genes of the Recovery Group According to the GO Molecular Function Terms. A, Downreg
Lanthascreen Eu Kinase Binding Assay for RPS6KA4 Overview
Targeting NRAS-Mutant Cancers with the Selective STK19 Kinase
Multi-Targeted Kinase Inhibition Alleviates Mtor Inhibitor
(RPS6KA4) (NM 003942) Human Recombinant Protein Product Data
Stimulation of the Insulin/Mtor Pathway Delays Cone Death in a Mouse Model of Retinitis Pigmentosa
JAX SOMASEQ TM Technical Specifications
Top View
Targeting PI3K in Cancer: Mechanisms and Advances in Clinical Trials Jing Yang, Ji Nie, Xuelei Ma, Yuquan Wei, Yong Peng and Xiawei Wei*
Kinome Expression Profiling to Target New Therapeutic Avenues in Multiple Myeloma
Identification of New Kinase Clusters Required for Neurite Outgrowth And
Table S1. List of Potential Positive and Negative Regulators of Telomerase
Mutations in the RAS-BRAF-MAPK-ERK Pathway
Genetic Variants in the PI3K/PTEN/AKT/Mtor Pathway Predict Head and Neck Cancer Patient Second Primary Tumor/Recurrence Risk and Response to Retinoid Chemoprevention
List of Actionable Genes and Potential Matched Therapy
A. Supplementary Figure 1
A Resource for Exploring the Understudied Human Kinome for Research and Therapeutic
Targets and Off-Targets of Kinase Inhibitors in Diabetes
Supporting Information for “A High-Throughput Targeted Proteomic Approach for Comprehensive
Kin-2787, Is Active in Class Ii and Class Iii Braf Mutant Models
Sunitinib-Containing Carborane Pharmacophore with the Ability To
Large-Scale Identification of Functional Genes Regulating Cancer Cell Migration and Metastasis Using the Self-Assembled Cell Microarray
E1321-Catching the Driver Mutations in Ewing Sarcoma Tumours: an In
S41467-020-15428-0.Pdf
Genes Interrogated by Mayocomplete Solid Tumor Panel
RT² Profiler PCR Array (96-Well Format and 384-Well [4 X 96] Format)
Mtor-Dependent Translation Amplifies Microglia Priming in Aging Mice
Probe Set ID Gene Symbol Gene Name Refseq Transcript ID Chrom . Loc. 1007 S at DDR1 Discoidin Domain Receptor Family, Member
Figure S1. Survival Rates of Zebrafish Embryos Trated with Lanthionine And/Or GSH
Erik Halcsik
Drugs and Epigenetic Molecular Functions. a Pharmacological Data Scientometric Analysis
A Novel CDK7 Inhibitor of the Pyrazolotriazine Class Exerts Broad- Spectrum Antiviral Activity at Nanomolar Concentrations
Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: a Validated Panel for Preclinical Studies
Profiling Data
Dysregulation of KRAS Signaling in Pancreatic Cancer Is Not Associated with KRAS Mutations and Outcome
Decision Summary
HDAC and MAPK/ERK Inhibitors Cooperate to Reduce Viability and Stemness in Medulloblastoma
Annotated Gene List HTG Edgeseq Autoimmune Panel
Scanmaxsm Kinase Assay Panel
Characterization and Clustering of Kinase Isoform Expression in Metastatic Melanoma
SUPPLEMENTARY INFORMATION Supplementary Methods
Revealing Different Roles of the Mtor-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis
Meta-Analysis of Genome-Wide Association Studies for Abdominal Aortic Aneurysm Identifies Four New Disease-Specific Risk Loci
Haploinsufficiency of RREB1 Causes a Noonan-Like Rasopathy Via
Ratio* Genes in Pathway Atherosclerosis Signaling 4.65
CDK/CK1 Inhibitors Roscovitine and CR8 Downregulate Amplified MYCN
View by Kinase Target
Active Kinase Manual
Supplementary Table 3
Electronic Supporting Information